GT200600011A - Procedimientos para preparar eteres de pirazolo [3,4-d] pirimidina - Google Patents
Procedimientos para preparar eteres de pirazolo [3,4-d] pirimidinaInfo
- Publication number
- GT200600011A GT200600011A GT200600011A GT200600011A GT200600011A GT 200600011 A GT200600011 A GT 200600011A GT 200600011 A GT200600011 A GT 200600011A GT 200600011 A GT200600011 A GT 200600011A GT 200600011 A GT200600011 A GT 200600011A
- Authority
- GT
- Guatemala
- Prior art keywords
- eteres
- pirazolo
- pyrimidine
- procedures
- prepare
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE LA FORMULA GENERAL I EN LA QUE R1,R2,R3,R5,R10,R13,R14,R15,R16,R17,M,N, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS SON MODULADORES DEL METABOLISMO DE LA GLUCOSA Y POR LO TANTO SON DE UTILIDAD EN EL TRATAMIENTO DE TRASTORNOS METABOLICOS TALES COMO LA DIABETES Y LA OBESIDAD.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64371205P | 2005-01-13 | 2005-01-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200600011A true GT200600011A (es) | 2006-08-10 |
Family
ID=36463499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200600011A GT200600011A (es) | 2005-01-13 | 2006-01-11 | Procedimientos para preparar eteres de pirazolo [3,4-d] pirimidina |
Country Status (22)
Country | Link |
---|---|
US (1) | US7425630B2 (es) |
EP (1) | EP1838713A2 (es) |
JP (1) | JP2008526975A (es) |
KR (1) | KR20070114126A (es) |
CN (1) | CN101142216A (es) |
AR (1) | AR052557A1 (es) |
AU (1) | AU2006204940A1 (es) |
BR (1) | BRPI0606115A2 (es) |
CA (1) | CA2593345A1 (es) |
CR (1) | CR9224A (es) |
DO (1) | DOP2006000009A (es) |
EA (1) | EA013968B1 (es) |
GT (1) | GT200600011A (es) |
HN (1) | HN2006001493A (es) |
IL (1) | IL184365A0 (es) |
MX (1) | MX2007008381A (es) |
NO (1) | NO20074052L (es) |
PA (1) | PA8659701A1 (es) |
PE (1) | PE20061118A1 (es) |
TW (1) | TW200637865A (es) |
WO (1) | WO2006076455A2 (es) |
ZA (1) | ZA200705279B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10238722A1 (de) | 2002-08-23 | 2004-03-11 | Bayer Ag | Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse |
US8293751B2 (en) | 2003-01-14 | 2012-10-23 | Arena Pharmaceuticals, Inc. | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
AU2004257267B2 (en) * | 2003-07-14 | 2009-12-03 | Arena Pharmaceuticals,Inc | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
US7923465B2 (en) * | 2005-06-02 | 2011-04-12 | Glenmark Pharmaceuticals S.A. | Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
US8648085B2 (en) | 2007-11-30 | 2014-02-11 | Boehringer Ingelheim International Gmbh | 1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders |
UA105362C2 (en) | 2008-04-02 | 2014-05-12 | Бьорингер Ингельхайм Интернациональ Гмбх | 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators |
AU2009270971A1 (en) * | 2008-07-16 | 2010-01-21 | Schering Corporation | Bicyclic Heterocycle Derivatives and use thereof as GPR119 modulators |
NZ590788A (en) | 2008-09-08 | 2012-11-30 | Boehringer Ingelheim Int | Pyrazolopyrimidines and their use for the treatment of cns disorders |
RS53167B (en) | 2009-03-31 | 2014-06-30 | Boehringer Ingelheim International Gmbh | 1-HETEROCYCLYL-1,5-DIHYDRO-PYRAZOLO [3,4-D] PYRIMIDIN-4-ONE DERIVATIVES AND THEIR APPLICATIONS AS A PDE9A MODULATOR |
US20100285145A1 (en) * | 2009-05-08 | 2010-11-11 | Pfizer Inc | Gpr 119 modulators |
NZ596467A (en) * | 2009-06-05 | 2014-01-31 | Pfizer | L- ( piperidin-4-yl) -pyrazole derivatives as gpr 119 modulators |
JP5856980B2 (ja) | 2010-01-27 | 2016-02-10 | アリーナ ファーマシューティカルズ, インコーポレイテッド | (R)−2−(7−(4−シクロペンチル−3−(トリフルオロメチル)ベンジルオキシ)−1,2,3,4−テトラヒドロシクロペンタ[b]インドール−3−イル)酢酸およびその塩の調製のためのプロセス |
GEP20156217B (en) | 2010-08-12 | 2015-01-12 | Boehringer Ingelheim Int | 6-cycloalkyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a inhibitors |
KR101871011B1 (ko) | 2010-09-22 | 2018-06-25 | 아레나 파마슈티칼스, 인크. | Gpr119 수용체의 조절제 및 그와 관련된 장애의 치료 |
US8809345B2 (en) | 2011-02-15 | 2014-08-19 | Boehringer Ingelheim International Gmbh | 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders |
AU2012267556B9 (en) | 2011-06-09 | 2017-05-11 | Rhizen Pharmaceuticals Sa | Novel compounds as modulators of GPR-119 |
JP6567276B2 (ja) * | 2014-05-13 | 2019-08-28 | ソニーセミコンダクタソリューションズ株式会社 | 固体撮像素子、および電子機器 |
WO2016090380A1 (en) * | 2014-12-06 | 2016-06-09 | Intra-Cellular Therapies, Inc. | Organic compounds |
UA126268C2 (uk) | 2015-01-06 | 2022-09-14 | Арена Фармасьютікалз, Інк. | СПОСОБИ ЛІКУВАННЯ СТАНІВ, ПОВ'ЯЗАНИХ З РЕЦЕПТОРОМ S1P<sub>1 </sub> |
EA201890096A1 (ru) | 2015-06-22 | 2018-08-31 | Арена Фармасьютикалз, Инк. | КРИСТАЛЛИЧЕСКАЯ L-АРГИНИНОВАЯ СОЛЬ (R)-2-(7-(4-ЦИКЛОПЕНТИЛ-3-(ТРИФТОРМЕТИЛ)БЕНЗИЛОКСИ)-1,2,3,4-ТЕТРАГИДРОЦИКЛОПЕНТА[b]ИНДОЛ-3-ИЛ)УКСУСНОЙ КИСЛОТЫ (СОЕДИНЕНИЯ 1) ДЛЯ ПРИМЕНЕНИЯ ПРИ РАССТРОЙСТВАХ, СВЯЗАННЫХ С S1P-РЕЦЕПТОРОМ |
US11534424B2 (en) | 2017-02-16 | 2022-12-27 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
JP2019122134A (ja) | 2018-01-04 | 2019-07-22 | Ntn株式会社 | スイッチング電源の力率改善用pwm制御装置 |
AU2022300325A1 (en) * | 2021-06-23 | 2023-11-02 | F. Hoffmann-La Roche Ag | Process for the preparation of nlrp3 inhibitors |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3070304D1 (en) | 1980-04-28 | 1985-04-25 | Teijin Ltd | Thiazolo(3,2-a)pyrimidine derivatives, process for preparing same, and drug containing same |
EP0053678A1 (de) | 1980-12-05 | 1982-06-16 | BASF Aktiengesellschaft | 5-Amino-1-phenyl-4-cyanpyrazole, diese enthaltende herbizide Mittel, Verfahren zu ihrer Herstellung und ihre Anwendung als Herbizide |
US4612376A (en) | 1983-03-25 | 1986-09-16 | Fujisawa Pharmaceutical Co., Ltd. | Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent |
GB9114760D0 (en) | 1991-07-09 | 1991-08-28 | Pfizer Ltd | Therapeutic agents |
JP4022271B2 (ja) * | 1995-10-31 | 2007-12-12 | 富士フイルム株式会社 | ピラゾリルアゾフエノール色素 |
US6921763B2 (en) * | 1999-09-17 | 2005-07-26 | Abbott Laboratories | Pyrazolopyrimidines as therapeutic agents |
EP1212327B8 (en) * | 1999-09-17 | 2004-02-25 | Abbott GmbH & Co. KG | Pyrazolopyrimidines as therapeutic agents |
DE10219435A1 (de) * | 2002-05-02 | 2003-11-13 | Bayer Cropscience Ag | Substituierte Pyrazolo-pyrimidin-4-one |
WO2004009602A1 (en) * | 2002-07-23 | 2004-01-29 | Smithkline Beecham Corporation | Pyrazolopyrimidines as kinase inhibitors |
AU2004257267B2 (en) * | 2003-07-14 | 2009-12-03 | Arena Pharmaceuticals,Inc | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
GB0425035D0 (en) | 2004-11-12 | 2004-12-15 | Novartis Ag | Organic compounds |
-
2006
- 2006-01-05 DO DO2006000009A patent/DOP2006000009A/es unknown
- 2006-01-09 TW TW095100806A patent/TW200637865A/zh unknown
- 2006-01-10 PE PE2006000054A patent/PE20061118A1/es not_active Application Discontinuation
- 2006-01-11 GT GT200600011A patent/GT200600011A/es unknown
- 2006-01-12 KR KR1020077018365A patent/KR20070114126A/ko not_active Application Discontinuation
- 2006-01-12 MX MX2007008381A patent/MX2007008381A/es active IP Right Grant
- 2006-01-12 CN CNA2006800064543A patent/CN101142216A/zh not_active Withdrawn
- 2006-01-12 AU AU2006204940A patent/AU2006204940A1/en not_active Withdrawn
- 2006-01-12 US US11/331,372 patent/US7425630B2/en not_active Expired - Fee Related
- 2006-01-12 JP JP2007551363A patent/JP2008526975A/ja not_active Withdrawn
- 2006-01-12 HN HN2006001493A patent/HN2006001493A/es unknown
- 2006-01-12 CA CA002593345A patent/CA2593345A1/en not_active Withdrawn
- 2006-01-12 BR BRPI0606115-0A patent/BRPI0606115A2/pt not_active IP Right Cessation
- 2006-01-12 EP EP06718131A patent/EP1838713A2/en not_active Withdrawn
- 2006-01-12 EA EA200701500A patent/EA013968B1/ru not_active IP Right Cessation
- 2006-01-12 PA PA20068659701A patent/PA8659701A1/es unknown
- 2006-01-12 WO PCT/US2006/001020 patent/WO2006076455A2/en active Application Filing
- 2006-01-12 AR ARP060100122A patent/AR052557A1/es not_active Application Discontinuation
-
2007
- 2007-07-02 IL IL184365A patent/IL184365A0/en unknown
- 2007-07-03 CR CR9224A patent/CR9224A/es unknown
- 2007-07-06 ZA ZA200705279A patent/ZA200705279B/xx unknown
- 2007-08-06 NO NO20074052A patent/NO20074052L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE20061118A1 (es) | 2006-10-13 |
WO2006076455A8 (en) | 2006-11-02 |
CA2593345A1 (en) | 2006-07-20 |
ZA200705279B (en) | 2008-11-26 |
CN101142216A (zh) | 2008-03-12 |
DOP2006000009A (es) | 2006-08-15 |
EA200701500A1 (ru) | 2007-12-28 |
US7425630B2 (en) | 2008-09-16 |
PA8659701A1 (es) | 2006-09-08 |
BRPI0606115A2 (pt) | 2009-06-02 |
WO2006076455A3 (en) | 2006-12-07 |
JP2008526975A (ja) | 2008-07-24 |
CR9224A (es) | 2007-10-23 |
HN2006001493A (es) | 2010-08-19 |
AR052557A1 (es) | 2007-03-21 |
MX2007008381A (es) | 2007-09-07 |
NO20074052L (no) | 2007-09-12 |
IL184365A0 (en) | 2007-10-31 |
TW200637865A (en) | 2006-11-01 |
US20060154940A1 (en) | 2006-07-13 |
AU2006204940A1 (en) | 2006-07-20 |
KR20070114126A (ko) | 2007-11-29 |
WO2006076455A2 (en) | 2006-07-20 |
EA013968B1 (ru) | 2010-08-30 |
EP1838713A2 (en) | 2007-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200600011A (es) | Procedimientos para preparar eteres de pirazolo [3,4-d] pirimidina | |
CR20150131A (es) | Derivados piridin-2-il-amino-1,2,4-tiadiazol como activadores glucoquinasa para el tratamiento de la diabetes mellitus | |
BRPI0911035B8 (pt) | ativadores de pirrolidinona glicoquinase | |
GT200800184A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevencion de diabetes. | |
ECSP10010599A (es) | Derivados de tienopiridonas como activadores de proteina quinasa activados por amp (ampk) | |
ATE528300T1 (de) | Bizyklische verbindungen und ihre verwendung als antidiabetika | |
ECSP109921A (es) | Sulfonamidas como moduladores de trpm8 | |
CL2009000990A1 (es) | Uso de epotilona d para el tratamiento de enfermedades asociadas a tau, tal como enfermedad alzheimer, parkinson, entre otras. | |
CR10948A (es) | Compuestos triciclicos, composiciones y procedimientos | |
ECSP10010654A (es) | Derivados de tienopiridonas como activadores de proteína quinasa activados por amp (ampk) | |
GT200500049A (es) | Derivados de 1,6-naftiridina y 1,8-naftiridina y su uso para tratar la diabetes y trastornos relacionados | |
CO6270312A2 (es) | Moduladores de gpr40 bifenilo-sustituidos | |
CL2009000135A1 (es) | Compuestos derivados de 1,4-benzodiazepinas sustituidas, inhibidores de dipeptidilpeptidasa iv (dpp-iv); composicion farmaceutica; procedimiento de preparacion; y su uso en el tratamiento de enfermedades tales como diabetes tipo 2, cataratas, glaucoma, hipertrofia prostatica benigna, cancer, entre otras; compuestos intermediarios. | |
GT200800103A (es) | 5-aril isoxazolinas para controlar plagas de invertebrados | |
GT200800258A (es) | Compuestos de pirrolo-pirimidina y sus usos | |
CO6220948A2 (es) | Derivados de ciclohexano espirociclico | |
MX2014014902A (es) | Composiciones que comprenden apomorfina y acidos organicos y usos de las mismas. | |
CL2011000249A1 (es) | Compuestos derivados de 2-[1-sustituido-1h-pirazolo[3,4-d]pirimidin-4-il](tio, oxi o amino)-n-(heteroaril)-alcanoamidas; con actividada moduladora de glucoquinasa glk o gk; composicion farmaceutica que comprende y uso en el tratamiento de la diabetes tipo 2 y obesidad. | |
PA8584001A1 (es) | Indol-3-carboxamidas como activadores de glucoquinasa (gk) | |
CL2007003733A1 (es) | Compuestos derivados de indolin-2-ona, bencimidazol-2-ona y benzoxazol-2-ona, moduladores de serina palmitoiltransferasa; composicion farmaceutica; y uso para el tratamiento de enfermedades tales como diabetes tipo 1 y 2, obesidad, aterosclerosis, hi | |
UY31803A (es) | Compuesto cristalino | |
MX2009007436A (es) | Derivados espirociclicos de acido tetronico. | |
DOP2006000087A (es) | Compuestos heteroaromaticos acilaminobiciclicos y sus usos | |
HN2010000330A (es) | DERIVADOS DE INDOL-2-ONA DISUSTITUIDOS EN 3 y SU PREPARACION | |
ATE552257T1 (de) | Positive allosterische chinolizidinon-m1- rezeptormodulatoren |